BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/27/2022 9:34:47 AM | Browse: 785 | Download: 1865
Publication Name World Journal of Gastrointestinal Surgery
Manuscript ID 73526
Country United States
ISSN 1948-9366 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Letter to the Editor
Article Title Advances and effectiveness of the immunotherapy after liver transplantation
Manuscript Source Invited Manuscript
All Author List Sai Swarupa R Vulasala, Nirmal K Onteddu, Sindhu P Kumar, Chandana Lall, Priya Bhosale and Mayur K Virarkar
ORCID
Author(s) ORCID Number
Sai Swarupa R Vulasala http://orcid.org/0000-0002-9387-3673
Nirmal K Onteddu http://orcid.org/0000-0002-6267-0240
Sindhu P Kumar http://orcid.org/0000-0002-3862-7453
Chandana Lall http://orcid.org/0000-0002-5318-4160
Priya Bhosale http://orcid.org/0000-0003-4014-4941
Mayur K Virarkar http://orcid.org/0000-0002-5825-3102
Funding Agency and Grant Number
Corresponding Author Sai Swarupa R Vulasala, MBBS, Research Assistant, Department of Radiology, University of Florida College of Medicine, 655 West 8th Street, C90, 2nd Floor, Clinical Center, Jacksonville, FL 32209, United States. vulasalaswarupa@gmail.com
Key Words Immunotherapy; Hepatocellular carcinoma; Immune checkpoint inhibitors; Liver transplantation; Solid organ transplant; Graft rejection
Core Tip There is an increased risk of cancer among transplant recipients receiving chronic immunosuppression. Immunotherapy has a beneficiary effect over immunosuppressors in reducing the overall cancer risk. However, there are very few studies that included solid organ transplant recipients while studying the efficacy of immunotherapy. “Immunotherapy after liver transplantation: Where are we now?” is a study, where the authors described the mechanism of action and outcomes of immune checkpoint inhibitors specific to liver transplant recipients.
Publish Date 2022-06-27 09:34
Citation Vulasala SSR, Onteddu NK, Kumar SP, Lall C, Bhosale P, Virarkar MK. Advances and effectiveness of the immunotherapy after liver transplantation. World J Gastrointest Surg 2022; 14(6): 629-631
URL https://www.wjgnet.com/1948-9366/full/v14/i6/629.htm
DOI https://dx.doi.org/10.4240/wjgs.v14.i6.629
Full Article (PDF) WJGS-14-629.pdf
Full Article (Word) WJGS-14-629.docx